Pharmafile Logo

long-term condition

- PMLiVE

Life joins the Indigenus communications network

Windsor-based agency will be network's new UK partner

- PMLiVE

Ireland and the impact of reference pricing

Industry remains tight-lipped on the country's pharmaceutical pricing changes

- PMLiVE

Dawn of the new world

What the new NHS means for pharma and healthcare comms

- PMLiVE

Amgen cholesterol antibody shines in rare disease trial

Evolocumab passes late-stage study

- PMLiVE

Marino Garcia joins Synergy Pharmaceuticals

He has experience in gastrointestinal market at Aptalis

TxCell plans listing as EU biotech wakes up to IPOs

Move follows UK allergy therapy developer Circassia's listing

- PMLiVE

How will the new landscape of hepatitis C treatments affect patients?

For this 22 April webinar we bring together a panel of experts in hepatitis C to discuss this important topic, including a healthcare funder, a pharma medical director and an...

Bristol-Myers Squibb (BMS) building

BMS strikes $350m deal to boost its immuno-oncology pipeline

Will collaborate with US biotech Five Prime Therapeutics

EU flag

European Commission sets out HIV/Aids action plan

Says two-year programme proves HIV/Aids remains an EU health policy priority

- PMLiVE

Serviceplan to work with Philipp Lahm

Bayern Munich star signs on as the face of PR firm's latest campaign for AOK

European elections – EFPIA launches social media campaign

Calls for integrated life sciences strategy for the EU

- PMLiVE

McCarthy leaves NHS England

Policy director set for move to the University of Bradford

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links